CD19x22 CAR T cells

· University of Colorado, Denver

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19x22 CAR T cells, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients [Phase 1]